Glenmark Pharmaceuticals 배당금 및 환매
배당금 기준 확인 2/6
Glenmark Pharmaceuticals 은(는) 현재 수익률이 0.17% 인 배당금 지급 회사입니다.
주요 정보
0.2%
배당 수익률
-0.003%
환매 수익률
| 총 주주 수익률 | 0.2% |
| 미래 배당 수익률 | 0.3% |
| 배당금 성장 | 0.3% |
| 다음 배당금 지급일 | n/a |
| 전 배당일 | n/a |
| 주당 배당금 | ₹2.500 |
| 지급 비율 | -4% |
최근 배당금 및 환매 업데이트
Glenmark Pharmaceuticals (NSE:GLENMARK) Is Paying Out A Dividend Of ₹2.50
Sep 06
Glenmark Pharmaceuticals (NSE:GLENMARK) Will Pay A Dividend Of ₹2.50
Sep 17Glenmark Pharmaceuticals (NSE:GLENMARK) Has Announced A Dividend Of ₹2.50
Aug 30Recent updates
Pinning Down Glenmark Pharmaceuticals Limited's (NSE:GLENMARK) P/S Is Difficult Right Now
Oct 26This Is Why Glenmark Pharmaceuticals Limited's (NSE:GLENMARK) CEO Compensation Looks Appropriate
Sep 21Glenmark Pharmaceuticals (NSE:GLENMARK) Is Paying Out A Dividend Of ₹2.50
Sep 06Calculating The Fair Value Of Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
Aug 06Does Glenmark Pharmaceuticals (NSE:GLENMARK) Have A Healthy Balance Sheet?
Jun 16Is Glenmark Pharmaceuticals Limited (NSE:GLENMARK) Expensive For A Reason? A Look At Its Intrinsic Value
May 08Glenmark Pharmaceuticals (NSE:GLENMARK) Takes On Some Risk With Its Use Of Debt
Mar 09Is Glenmark Pharmaceuticals (NSE:GLENMARK) Using Too Much Debt?
Dec 07Shareholders Will Probably Hold Off On Increasing Glenmark Pharmaceuticals Limited's (NSE:GLENMARK) CEO Compensation For The Time Being
Sep 23Glenmark Pharmaceuticals (NSE:GLENMARK) Will Pay A Dividend Of ₹2.50
Sep 17Glenmark Pharmaceuticals (NSE:GLENMARK) Has Announced A Dividend Of ₹2.50
Aug 30A Look At The Intrinsic Value Of Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
Aug 28We Think Glenmark Pharmaceuticals (NSE:GLENMARK) Is Taking Some Risk With Its Debt
Jul 03A Look At The Fair Value Of Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
May 28Glenmark Pharmaceuticals (NSE:GLENMARK) Has A Somewhat Strained Balance Sheet
Mar 22Estimating The Fair Value Of Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
Feb 14An Intrinsic Calculation For Glenmark Pharmaceuticals Limited (NSE:GLENMARK) Suggests It's 37% Undervalued
Oct 12Shareholders Will Probably Hold Off On Increasing Glenmark Pharmaceuticals Limited's (NSE:GLENMARK) CEO Compensation For The Time Being
Sep 21Glenmark Pharmaceuticals (NSE:GLENMARK) Has Announced A Dividend Of ₹2.50
Aug 29We Think Glenmark Pharmaceuticals (NSE:GLENMARK) Can Stay On Top Of Its Debt
Jun 20There May Be Reason For Hope In Glenmark Pharmaceuticals' (NSE:GLENMARK) Disappointing Earnings
Jun 04An Intrinsic Calculation For Glenmark Pharmaceuticals Limited (NSE:GLENMARK) Suggests It's 27% Undervalued
May 05If You Like EPS Growth Then Check Out Glenmark Pharmaceuticals (NSE:GLENMARK) Before It's Too Late
Mar 25결제의 안정성과 성장
배당금 데이터 가져오기
안정적인 배당: GLENMARK 의 주당 배당금은 지난 10 년 동안 안정적이었습니다.
배당금 증가: GLENMARK 의 배당금 지급은 지난 10 년 동안 증가했습니다.
시장 대비 배당 수익률
| Glenmark Pharmaceuticals 시장 대비 배당 수익률 |
|---|
| 세그먼트 | 배당 수익률 |
|---|---|
| 회사 (GLENMARK) | 0.2% |
| 시장 하위 25% (IN) | 0.3% |
| 시장 상위 25% (IN) | 1.2% |
| 업계 평균 (Pharmaceuticals) | 0.7% |
| 애널리스트 예측 (GLENMARK) (최대 3년) | 0.3% |
주목할만한 배당금: GLENMARK 의 배당금( 0.17% )은 Indian 시장( 0.25% ).
고배당: GLENMARK 의 배당금( 0.17% )은 Indian 시장에서 배당금 지급자의 상위 25% 1.17% ).
주주에 대한 수익 배당금
수익 보장: GLENMARK 배당금을 지급하고 있지만 회사는 수익성이 없습니다.
주주에 대한 현금 배당금
현금 흐름 범위: GLENMARK 배당금을 지급하고 있지만 회사에는 잉여현금흐름이 없습니다.